MLICM
XLNX

Metropolitan Life Insurance Company (MetLife)’s Xilinx Inc XLNX Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio XLNX Stock Details XLNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-39,373
Closed -$8.35M – 2807
2021
Q4 		$8.35M Sell
39,373
-764
-2% -$151K 0.11% 137
2021
Q3 		$6.06M Sell
40,137
-1,173
-3% -$172K 0.09% 181
2021
Q2 		$5.98M Sell
41,310
-1,218
-3% -$155K 0.08% 186
2021
Q1 		$5.27M Sell
42,528
-2,407
-5% -$321K 0.08% 195
2020
Q4 		$6.37M Sell
44,935
-1,967
-4% -$256K 0.1% 162
2020
Q3 		$4.89M Sell
46,902
-1,756
-4% -$180K 0.08% 189
2020
Q2 		$4.79M Sell
48,658
-316
-0.6% -$28K 0.08% 190
2020
Q1 		$3.82M Sell
48,974
-1,065
-2% -$92.8K 0.08% 211
2019
Q4 		$4.89M Sell
50,039
-143
-0.3% -$13.4K 0.08% 215
2019
Q3 		$4.81M Sell
50,182
-80
-0.2% -$8.75K 0.08% 217
2019
Q2 		$5.93M Buy
50,262
+2,638
+6% +$308K 0.1% 177
2019
Q1 		$6.04M Sell
47,624
-1,831
-4% -$206K 0.11% 159
2018
Q4 		$4.21M Sell
49,455
-494
-1% -$41.3K 0.08% 198
2018
Q3 		$4M Sell
49,949
-1,207
-2% -$88.3K 0.07% 234
2018
Q2 		$3.34M Buy
51,156
+844
+2% +$57.5K 0.05% 291
2018
Q1 		$3.63M Buy
50,312
+1,136
+2% +$81.9K 0.05% 268
2017
Q4 		$3.31M Sell
49,176
-79,078
-62% -$5.61M 0.04% 300
2017
Q3 		$9.08M Sell
128,254
-1,606
-1% -$105K 0.06% 302
2017
Q2 		$8.35M Buy
129,860
+3,428
+3% +$216K 0.06% 310
2017
Q1 		$7.32M Sell
126,432
-3,551
-3% -$209K 0.05% 370
2016
Q4 		$7.85M Sell
129,983
-3,893
-3% -$209K 0.06% 321
2016
Q3 		$7.28M Sell
133,876
-1,313
-1% -$67.5K 0.05% 344
2016
Q2 		$6.24M Sell
135,189
-1,412
-1% -$64.5K 0.05% 409
2016
Q1 		$6.48M Sell
136,601
-3,031
-2% -$142K 0.05% 387
2015
Q4 		$6.56M Sell
139,632
-3,389
-2% -$160K 0.05% 366
2015
Q3 		$6.06M Sell
143,021
-2,541
-2% -$107K 0.04% 408
2015
Q2 		$6.43M Sell
145,562
-10,473
-7% -$472K 0.05% 418
2015
Q1 		$6.6M Sell
156,035
-3,519
-2% -$144K 0.05% 401
2014
Q4 		$6.91M Sell
159,554
-2,510
-2% -$109K 0.05% 378
2014
Q3 		$6.86M Sell
162,064
-2,751
-2% -$120K 0.05% 369
2014
Q2 		$7.8M Sell
164,815
-6,228
-4% -$300K 0.05% 359
2014
Q1 		$9.28M Sell
171,043
-3,406
-2% -$169K 0.06% 305
2013
Q4 		$8.01M Sell
174,449
-1,888
-1% -$84.9K 0.06% 347
2013
Q3 		$8.26M Buy
176,337
+64
+0% +$2.88K 0.06% 324
2013
Q2 		$6.98M Buy
+176,273
New +$6.77M 0.06% 352

Other funds holding XLNX

PI
PGGM Investments Zeist, Netherlands $4.06B AUM 24.91% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
ACA
Atlas Capital Advisors Jackson, Wyoming $875M AUM
NEWAS
N.E.W. Advisory Services De Pere, Wisconsin $1.5B AUM 19.48% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s XLNX Position: Q1 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Xilinx Inc (XLNX) in Q1 2022, closing a stake of 39,373 shares — an estimated $8.35M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in XLNX in Q2 2013 and held it in 35 quarters. The position peaked at $9.28M in Q1 2014. 4 funds tracked by Wall St. Rank hold XLNX as of Q1 2022.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Xilinx Inc position as of Q1 2022 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 39,373 Xilinx Inc shares in Q1 2022, an estimated $8.35M.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Xilinx Inc in Q2 2013 and held it in 35 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Xilinx Inc position peaked at $9.28M in Q1 2014.
  • 4 funds tracked by Wall St. Rank held Xilinx Inc as of Q1 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.